This whitepaper provides an overview of the regulatory challenges posed by the detection of nitrosamine impurities in pharmaceutical products.

In this white paper, we provide an overview of the regulatory challenges posed by the detection of nitrosamine impurities in pharmaceutical products. We also highlight the impact of nitrosamine contamination on the industry, industry collaboration, and the publication of research to aid prevention efforts.

Download Now

Asset 7: Changing regulatory environment for nitrosamine impurities

PDF, Size 0 kb

Topics